Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. | Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 2003 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations Leiden, NL HQ | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 2864% decrease | Employees 196% increase | Employees 172 |
Financial | |||
Net income | Net income ($255.3m) (FY, 2019) | Net income N/A | Net income ($154.9m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 11m | Total funding raised $ 149.3m |